Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
Journal of Psychopharmacology (Oxford, England)|October 20, 2006
The other face of depression, reduced positive affect: the role of catecholamines in causation and cureDavid Nutt, Koen Demyttenaere, Zoltan Janka, et al.
Human Psychopharmacology|January 16, 2014
A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteersDavid Christmas, Alison Diaper, Sue Wilson, et al.
Psychopharmacology|November 4, 2021
Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online surveyJoanna Kuc, Hannes Kettner, Fernando Rosas, et al.
European Addiction Research|August 14, 2017
A Brief Outline of the Use of New Technologies for Treating Substance Use Disorders in the European UnionGianLuca Quaglio, Arnt Schellekens, Matthijs Blankers, et al.
Molecular Psychiatry|April 25, 2025
Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesRebecca Harding, Neomi Singer, Matthew B Wall, et al.
Neuroimage|June 28, 2019
Spectral signatures of serotonergic psychedelics and glutamatergic dissociativesCarla Pallavicini, Martina G Vilas, Mirta Villarreal, et al.
Journal of Analytical Toxicology|November 6, 2015
Validated Method for the Quantification of Baclofen in Human Plasma Using Solid-Phase Extraction and Liquid Chromatography-Tandem Mass SpectrometryLimon Khatun Nahar, Rosa Elena Cordero, David Nutt, et al.
Neuropsychologia|April 10, 2016
A placebo-controlled investigation of synaesthesia-like experiences under LSDDevin B Terhune, David P Luke, Mendel Kaelen, et al.
EJNMMI Physics|March 10, 2026
Evaluation of the impact of low activity imaging in [11C]-(+)-PHNO and [11C]UCB-J PET-MR scansDaniela Ribeiro, William Hallett, Oliver Howes, et al.
Frontiers in Psychology|September 4, 2018
DMT Models the Near-Death ExperienceChristopher Timmermann, Leor Roseman, Luke Williams, et al.
Pageof 19